SAN DIEGO, Jan. 15, 2018 /PRNewswire/ -- Luna DNA, the
first and only genomic and medical research knowledge base powered
by the blockchain and owned by its community, announced today
Dawn Barry as president. In this
role, Barry will be responsible for leading operations,
communicating and implementing company mission, and guiding overall
strategy, direction, and growth.
Barry will present at the 13th Precision Medicine World
Conference (PMWC) on January 24,
2018, in Silicon Valley. Her talk will address how Luna DNA
will leverage the blockchain for revolutionizing how medical
research is conducted. Co-hosted with Stanford Health Care, UCSF,
University of Michigan, Duke University, Duke Health, and Johns Hopkins, PMWC will cover disruptive
approached and technologies in personalized medicine.
"Dawn's many years of experience in strategic development
of emerging markets and dedication to genomic discovery make
her the ideal fit for the role," said Bob
Kain, CEO and co-founder, Luna DNA. "She shares the team's
passion for improving human health through community participation
to harness the power of the genome."
Previously, Barry served as the vice president of Applied
Genomics at Illumina (NASDAQ: ILMN) where she integrated market
development strategies with product and business model innovation
to accelerate the application of genomics in medicine and personal
healthcare. Barry joined Illumina in 2005 as its first market
development specialist and has since held leadership roles in
business units, sales, and marketing for the company.
"With the intersection of genomics and the blockchain, in
addition to the emergence of digital currencies, it became clear
this was the time to get involved with a company building something
truly unique to the space of medical discovery," said Barry. "I'm
thrilled to be joining Luna DNA where we can make a difference not
only within communities but globally. Individuals engaging
with researchers and being able to own, control and be rewarded for
sharing their data is the right thing to do for science and for
individuals who have the power to drive healthier communities."
Prior to Illumina, Barry spent seven years at Genaissance
Pharmaceuticals, one of the first genomics startups focused on
individualized medicine and DNA-based diagnostic testing, with the
primary responsibility of promoting clinical genetics testing
services for pharmaceutical clinical trials. She holds a BS in
biology from the University of Vermont
and a MBA from the University of
Connecticut School of Business.
Barry spoke on the topic of sequencing the human genome at
TEDxSan Diego and was honored as 2017 Business Woman of the Year by
San Diego Business Journal.
Luna DNA recently announced its launch and Seed funding round
close. Following the appointment of Barry as president, Luna DNA
plans to build-out its community, which rewards data contributions
with Luna Coins, its own unique
digital currency.
About Luna DNA
Luna DNA is the first and only genomic
and medical research database powered by the blockchain and owned
by its community. A Public Benefit Corporation, Luna DNA enables
people to own and share their genomic information for the greater
good of the community and medical research. The company is
headquartered in San Diego, Calif.
and was founded in 2017. Luna DNA encompasses a robust executive
leadership team and advisory board, including several Illumina
veterans, industry academics, and financial executives.
For more information visit www.lunadna.com.
Contact: Saramaya Penacho
BAM Communications
208-610-3375
saramaya@bamcommunications.biz
View original content with
multimedia:http://www.prnewswire.com/news-releases/luna-dna-announces-dawn-barry-former-illumina-vp-as-president-300582411.html
SOURCE Luna DNA